BiomX (NYSEAMERICAN:PHGE) Stock Price Down 8.2%

BiomX Inc. (NYSEAMERICAN:PHGE) shares dropped 8.2% on Thursday . The stock traded as low as $0.41 and last traded at $0.41. Approximately 145,054 shares changed hands during trading, a decline of 93% from the average daily volume of 1,998,794 shares. The stock had previously closed at $0.44.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and set a $2.00 price objective on shares of BiomX in a research note on Wednesday, April 3rd.

BiomX Stock Performance

The company has a market capitalization of $22.53 million, a price-to-earnings ratio of -0.77 and a beta of 1.31. The company has a debt-to-equity ratio of 1.75, a current ratio of 1.58 and a quick ratio of 1.58.

BiomX (NYSEAMERICAN:PHGE) last issued its earnings results on Wednesday, April 3rd. The company reported ($0.08) EPS for the quarter. On average, research analysts anticipate that BiomX Inc. will post -0.25 earnings per share for the current year.

Institutional Trading of BiomX

An institutional investor recently bought a new position in BiomX stock. 8VC GP I LLC acquired a new position in shares of BiomX Inc. (NYSEAMERICAN:PHGE) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,086,191 shares of the company’s stock, valued at approximately $304,000. BiomX makes up approximately 0.3% of 8VC GP I LLC’s portfolio, making the stock its 3rd largest holding. 8VC GP I LLC owned about 2.36% of BiomX as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 40.57% of the company’s stock.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).